While VEGF polymorphisms provide important insights into genetic susceptibility, their impact is likely limited compared to more direct and modifiable clinical factors, underscoring the necessity of addressing these high-risk elements for effective BPD prevention and management. Here, VEGFA is linked to bronchopulmonary dysplasia.